Jul 31 2016
Nanalyze
Stealthy Auris Health, Inc., formerly known as Auris Surgical Robotics, made the list of 10 robotic surgery companies to be watched. According to the article, robotic technology may be a less invasive approach with higher success rates, in comparison to today’s more traditional approaches. Auris was specifically mentioned for its impressive funding and 2016 FDA clearance for its robotic endoscopy system, ARES (Auris Robotic Endoscopy System).
Excerpts from the article: “It’s only a matter of time before the majority of skilled tasks are threatened by artificial intelligence and sophisticated automation techniques like robotics.”
“Auris received FDA clearance this year for a teleoperated robotic endoscopy system called ARES (Auris Robotic Endoscopy System). A recent article by IEEE talks in detail about what this stealth-mode Company might be up to, including a focus on endolumenal surgery which involves introducing flexible robots via the body’s natural openings (the mouth in particular).”
Read More About AurisBronchoscopy:
Complications from bronchoscopy are rare and most often minor, but if they occur, may include breathing difficulty, vocal cord spasm, hoarseness, slight fever, vomiting, dizziness, bronchial spasm, infection, low blood oxygen, bleeding from biopsied site, or an allergic reaction to medications. Only rarely do patients experience other more serious complications (for example, collapsed lung, respiratory failure, heart attack and/or cardiac arrhythmia).
Urology:
Adverse effects from both Mini-PCNL and Ureteroscopy include pain, urinary tract infection, fever, hematuria (presence of blood in urine), exposure to low levels of radiation, retained or residual stones.
Adverse effects from ureteroscopy may include pain, perforation or injury to the ureter, resulting in extravasation of fluid and urine (urinoma), stricture of the ureter with risk of subsequent obstruction (hydronephrosis needing further repair), rare avulsion of the ureter, urinary blood clots, residual stones.
PCNL access may result in minor and major adverse effects. Minor effects include fever and nephrostomy leak. Major adverse effects may include injuries to pleura, liver, spleen, large vessels with related bleeding, gallbladder, duodenum, jejunum, colon with related cutaneous fistula, fever, pain, ileus, elevated counts.
Major adverse effects related to stone removal may include infection and urosepsis, intravascular fluid overload, extravasation of fluid, and post percutaneous nephrolithotomy bleeding.